Value proposition

Better Human Disease Models

World leaders in iPSC technology supporting the next generation of advanced models for drug discovery

We provide biopharma and virtual organizations with human iPSC-derived cells and outsourced laboratory services to support drug discovery in the neurodegenerative, neuroinflammatory, and cardiotoxicity areas.

As leaders in human induced pluripotent stem cell (iPSC) products and services, we support the pursuit of more human-relevant in vitro models to develop better, safer therapies. We have over a decade of experience supplying top ten Biopharma institutions and drug discovery companies with robust, high-quality in vitro models and custom lab services.

Our industry-leading iPSC capabilities support the pursuit of advanced in vitro disease models and supply volume for organ-on-a-chip devices and microfluidics platforms. From simple monoculture models to complex co- and tri-culture and 3D models, we continue to pioneer the advanced utility of iPSCs for research and drug discovery.

iPSC derived cells, iPSC laboratory services, iPSC reprogramming, iPSC differentiation, iPSC gene editing, iPSC derived neurons, iPSC derived microglia, and iPSC cardiomyocytes